32 Bio Sciences

32 Bio Sciences develops drugs that work by modulating the biological activity of the gut microbiome to prevent diseases. Its platform technology generated a lead asset (CS-0003) that modulates bacterial virulence and restores microbial communities to prevent post-surgical infection. 32 Bio Sciences’ approach is transformative to the field and the world is taking notice. In…